首页|叶酸对非酒精性脂肪肝大鼠SOD、GSH-Px、GSH、MDA水平的影响

叶酸对非酒精性脂肪肝大鼠SOD、GSH-Px、GSH、MDA水平的影响

扫码查看
目的 研究叶酸对非酒精性脂肪肝(NAFLD)大鼠超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)、谷胱甘肽(GSH)、丙二醛(MDA)水平的影响.方法 取SD大鼠用高脂饲料喂养8周构建NAFLD模型,随机分为模型组、叶酸低剂量组(10 mg/kg)、叶酸中剂量组(20 mg/kg)、叶酸高剂量组(40 mg/kg)、奥利司他组(阳性对照药物,60 mg/kg),每组10只,再次取10只SD大鼠用正常饲料喂养8周作为对照组,使用叶酸和奥利司他分组处理后检测大鼠血脂总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、三酰甘油(TG)及游离脂肪酸(FFA)水平与肝功能指标谷丙转氨酶(ALT)、谷氨酰转肽酶(γ-GT)、谷草转氨酶(AST)水平;采用HE染色、油红O染色分别检测大鼠肝组织形态及脂肪变性,比较各组NAFLD活动度积分;采用试剂盒检测大鼠血清及肝组织SOD、GSH-Px、GSH、MDA水平.结果 与对照组相比,模型组大鼠肝组织发生明显脂肪变性与病理损伤,血清TC、LDL-C、TG、FFA、ALT、γ-GT与AST水平、NAFLD活动度积分、血清与肝组织MDA水平显著升高(P<0.05),血清与肝组织SOD、GSH-Px、GSH水平显著降低(P<0.05);与模型组相比,叶酸低、中、高剂量组大鼠肝组织脂肪变性与病理损伤均减轻且其减轻程度随剂量升高而增强,血清TC、LDL-C、TG、FFA、ALT、γ-GT与AST水平、NAFLD活动度积分、血清与肝组织MDA水平均降低(P<0.05),血清与肝组织SOD、GSH-Px、GSH水平均升高(P<0.05),并呈剂量依赖性(P<0.05);与叶酸高剂量组相比,奥利司他组大鼠各指标无明显变化(P>0.05).结论 叶酸可降低NAFLD大鼠血脂水平,增强其抗氧化酶活性并降低脂质过氧化水平,抑制其氧化应激,进而减轻大鼠肝组织脂肪变性、病理损伤并改善其肝功能.
Impacts of folic acid on the levels of SOD,GSH-Px,GSH and MDA in non-alcoholic fatty liver rats
Objective To investigate the impacts of folic acid on the levels of superoxide dismutase(SOD),glutathione peroxidase(GSH-Px),glutathione(GSH),and malondialdehyde(MDA) in non-alcoholic fatty liver disease (NAFLD) rats.Methods Sprague-Dawley(SD) rats were fed with high-fat diet for 8 weeks to construct a NAFLD model.They were randomly separated into the model group,low-dose folic acid group(10 mg/kg),medium-dose folic acid group(20 mg/kg),high-dose folic acid group(40 mg/kg),and Orlistat group(60 mg/kg positive control drug),with 10 rats in each group.Another 10 SD rats were fed with normal diet for 8 weeks were included as the control group. After treatment with folic acid and Orlistat,the levels of total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C),triglyceride(TG),and free fatty acid(FFA) in rat blood lipids,and liver function indicators like alanine aminotransferase (ALT),γ-glutamyl transpeptidase(γ-GT),and aspartate aminotransferase(AST) were detected.H&E staining and Oil Red O staining were respectively applied to detect the morphology and steatosis of rat liver tissue.The NAFLD activity scores of each group were compared.Reagent kits were applied to detect the levels of SOD,GSH-Px,GSH,and MDA in rat serum and liver tissue.Results Compared with those of the control group,rats in the model group showed obvious steatosis and pathological damage in the liver,significantly higher serum levels of TC,LDL-C,TG,FFA,ALT,γ-GT and AST,NAFLD activity score,and MDA in serum and liver tissue,but significantly lower SOD,GSH-Px,and GSH in serum and liver tissue(P<0.05).Compared with those of the model group,rats in the low,medium,high-dose folic acid groups had reduced steatosis and pathological damage in the liver tissue,significantly lower serum levels of TC,LDL-C,TG,FFA,ALT,γ-GT and AST,NAFLD activity score,and MDA in serum and liver tissue,but significantly higher SOD,GSH-Px,and GSH in serum and liver tissue in a dose-dependent manner(P<0.05).Compared with the high-dose folic acid group,all indicators were similar to the Orlistat group(P>0.05).Conclusion Folic acid can reduce blood lipid levels,enhance antioxidant enzyme activity,lower lipid peroxidation levels,and inhibit oxidative stress in NAFLD rats,thereby reducing hepatic steatosis,pathological damage,and improving liver function in rats.

Folic acidNon-alcoholic fatty liver diseaseOxidative stress

张菁楠、王慧然、郑帅、于雪

展开 >

牡丹江医科大学附属红旗医院药学部,黑龙江牡丹江 157011

叶酸 非酒精性脂肪肝 氧化应激

2025

中国疗养医学
中国煤矿工人北戴河疗养院

中国疗养医学

影响因子:0.584
ISSN:1005-619X
年,卷(期):2025.34(1)